Feto Naser Aliye, Asuzu Peace, Wan Jim, Stentz Frankie, Dagogo-Jack Sam, Mandal Nawajes
Departments of Ophthalmology, Anatomy and Neurobiology, University of Tennessee Health Science Center, 930 Madison Ave., Memphis, TN, 38163, USA.
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Biogerontology. 2025 May 5;26(3):106. doi: 10.1007/s10522-025-10244-9.
Sphingolipids (SPLs) are essential membrane lipids with significant bioactive roles involved in various cellular processes, and their alterations have been found to be linked to many diseases, including age-related diseases. However, comprehensive studies on the association of plasma sphingolipids with aging in large, diverse cohorts remain limited. The objective of this study was to investigate the relationship between plasma sphingolipid levels and aging in a cohort of 240 normoglycemic, biracial individuals (Black and White), aged 19-65 years. Using a targeted lipidomics approach, we measured 76 sphingolipid species using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in picomole/mL and determined changes in their levels with age and their correlations with aging. We found significant age-related changes in several sphingolipid species, including ceramide C18:1 and several very long-chain sphingomyelins (VLC SMs), such as C28:1 and C30:1, increases with age, showing a positive correlation. On the other hand, glycosphingolipids (monohexosylceramide, MHC; lactosylceramide, LacCer) and sphingosine (So) showed strong negative correlations with aging. A significant correlation was also observed between the ratios of saturate/monosaturated sphingolipid species with aging. In conclusion, our findings provide novel insights into the dynamic changes of circulating sphingolipids with aging. Specific sphingolipid species, such as Ceramide C18:1 and SM, accumulate with age, while others, including MHC, LacCer, and So decrease. These results suggest that the plasma SPL profile may provide valuable information about healthy aging and age-associated disease conditions.
鞘脂(SPLs)是重要的膜脂,在各种细胞过程中发挥着重要的生物活性作用,并且已发现它们的改变与许多疾病相关,包括与年龄相关的疾病。然而,在大型、多样化队列中关于血浆鞘脂与衰老关联的全面研究仍然有限。本研究的目的是在一个由240名年龄在19至65岁之间的血糖正常、混血(黑人和白人)个体组成的队列中,研究血浆鞘脂水平与衰老之间的关系。我们采用靶向脂质组学方法,使用液相色谱 - 串联质谱(LC-MS/MS)以皮摩尔/毫升为单位测量了76种鞘脂种类,并确定了它们的水平随年龄的变化及其与衰老的相关性。我们发现几种鞘脂种类存在显著的年龄相关变化,包括神经酰胺C18:1和几种超长链鞘磷脂(VLC SMs),如C28:1和C30:1,其随着年龄增长而增加,呈现正相关。另一方面,糖鞘脂(单己糖神经酰胺,MHC;乳糖基神经酰胺,LacCer)和鞘氨醇(So)与衰老呈现强烈的负相关。饱和/单不饱和鞘脂种类的比率与衰老之间也观察到显著相关性。总之,我们的研究结果为循环鞘脂随衰老的动态变化提供了新的见解。特定的鞘脂种类,如神经酰胺C18:1和鞘磷脂,会随着年龄积累,而其他种类,包括MHC、LacCer和So则会减少。这些结果表明,血浆SPL谱可能为健康衰老和与年龄相关的疾病状况提供有价值的信息。